Please Wait
Applying Filters...
menu
    • menu
    Seqens CDMO-PSE
    News
    Aether signs agreement with SEQENS for bio-based products

    22 Aug 2024

    // CNBC

    Boehringer Cuts Ties To Nxera's Phase 2-Ready Schizophrenia Drug

    20 Dec 2025

    // FIERCE BIOTECH

    Evaxion provides update on MSD collab For Gonorrhea EVX-B2

    20 Dec 2025

    // FIERCE BIOTECH

    Data Compilation
    #PharmaFlow

    Seqens

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-lupin-s-cdmo-commissions-oncology-block-in-india-cambrex-axplora-hovione-expand-operations
    Menu

    Chemoxy

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Aether signs agreement with SEQENS for bio-based products
    Aether signs agreement with SEQENS for bio-based products

    22 Aug 2024

    // CNBC

    https://www.cnbctv18.com/market/stocks/aether-industries-signs-exclusive-manufacturing-agreement-with-seqens-for-bio-based-products-19463893.htm

    CNBC
    22 Aug 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.